Parkinson's disease experts devise a roadmap
A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson's disease (PD). Experts in the ...
Dec 20, 2018
0
0